This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Anna Illarionova: Innovator in Gene Silencing
Introduction
Anna Illarionova is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of gene therapy, particularly through her innovative work on modified parvoviruses.
Latest Patents
Anna holds a patent for a "Modified parvovirus useful for gene silencing." This patent describes methods for efficiently down-regulating the expression of a gene of interest in a cell by utilizing a modified rodent parvovirus that contains an expressible target-specific nucleic acid, preferably an shRNA expression cassette. The patent also details cells or organisms that comprise this parvovirus.
Career Highlights
Anna is affiliated with the Deutsches Krebsforschungszentrum, where she conducts her research and development. Her work has been instrumental in advancing the understanding of gene silencing techniques.
Collaborations
Anna has collaborated with notable colleagues, including Antonio Marchini and Jean Rommelaere, who have contributed to her research endeavors.
Conclusion
Anna Illarionova's innovative work in gene silencing through modified parvoviruses showcases her dedication to advancing medical science. Her contributions are paving the way for future developments in gene therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile